Page 21 - Vaccine

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

A new vaccine regime

Govt conducts welcome course correction

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

EAM Jaishankar rejects criticism over export of coronavirus vaccines

At an online interaction, he said India prioritised vaccination of its people while describing those as "non-serious" people who questioned why the country was exporting at all

Expanding vaccine supply

Some good moves but freer pricing needed

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Best of BS Opinion: Rise of risk capital, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The supply side

Ramping up vaccine availability has become critical

Coping with Covid

We need to stop messing around and plan ahead of the infection curve

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Best of BS Opinion: The mis-selling menace, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states

Vaccination drive: An Utsav without utsah

After watching the government mess up its handling of Covid, people want a strategy, not participatory stunts

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

Fast-track Covid-19 vaccine approval gives indices a shot in the arm

Sensex, Nifty rise 1.4%; experts see volatility continuing in near term

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose

Failure on vaccines

Refusal to support private sector has led to a roll-out flop